COPENHAGEN, Denmark--(BUSINESS WIRE)--Symphogen A/S announced today that Ian Nicholson, B.Sc., MBA, has joined its Board of Directors. Mr. Nicholson is currently Chief Executive Officer of Chroma Therapeutics Limited and brings to Symphogen 25 years of experience in biotechnology business development, sales, and marketing.
